Community
Advertising Opportunities
Biotechnology Europe Programs
Biotechnology Europe Community
Feedback
Contact
Biotechnology Europe Advantages
Advertising Opportunities on Biotechnology Europe
Sponsorship Opportunities on Biotechnology Europe
Post a Job on Biotechnology Europe
Post a Company Profile on Biotechnology Europe
Post a News on Biotechnology Europe
Post an Event on Biotechnology Europe
Post a Product on Biotechnology Europe
Post a Publication on Biotechnology Europe
Post a Technology on Biotechnology Europe
Post a Resume on Biotechnology Europe
Terms of Business
Imprint
Privacy Policy
FAQ
Subscribe Newsletter
CLINICAL TRIALS NEWS
18.09.2007 MorphoSys AG Announces Clinical Milestone in Antibody Program - Fourth HuCAL-based Antibody to Begin Clinical Trials
05.09.2007 Merck: Stimuvax® Therapeutic Cancer Vaccine – Phase II Data Highlight Three-Year Survival Results for Lung Cancer Patients
16.07.2007 ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate
11.07.2007 Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
07.07.2007 Cancer-Fighting Virus Shows Promise in Early Clinical Trial
29.06.2007 Merck’s Fertility Treatment Pergoveris Approved in European Union
28.06.2007 European Union CHMP Recommends Approval of New Formulation of Multiple Sclerosis Treatment Rebif® (interferon beta-1a)
26.06.2007 ACADIA Pharmaceuticals Initiates Phase IIb Clinical Trial with ACP-104 in Patients with Schizophrenia
26.06.2007 Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
14.06.2007 New positive pre-clinical data for Active Biotech's RA project I-3D
07.06.2007 Cipralex® demonstrates superiority to duloxetine for acute treatment of depression in new study
07.06.2007 MediGene AG to Present at the Needham Biotechnology and Medical Technology Conference
07.06.2007 Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
07.06.2007 Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
07.06.2007 Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
02.06.2007 Second Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in First-Line Non-Squamous, Non-Small Cell Lung Cancer
02.06.2007 Phase III Study Shows Avastin Plus Interferon Therapy Nearly Doubled Median Progression-Free Survival in Patients with Previously Untreated Advanced Kidney Cancer
15.05.2007 MOLOGEN AG invests into pre-clinical studies in the first quarter of 2007
16.04.2007 Aranesp(R) Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
29.03.2007 ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
22.03.2007 Amgen Discontinues Vectibix(TM) Treatment in PACCE Trial Evaluating Vectibix(TM) as Part of Triple Combination Regimen
22.03.2007 Additional Data From Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
19.03.2007 ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial
09.03.2007 Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer
22.02.2007 Analysis of International Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
05.02.2007 Amarin Announces Completion Of Two Phase III Trials With Miraxion In Huntington's Disease
02.02.2007 Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis
24.01.2007 First Actemra multinational phase III trial demonstrates significant improvement in signs and symptoms of rheumatoid arthritis
10.01.2007 Oxford Biomedica's Phase Ill Trial of TroVax® in Renal Cancer Adopted by UK Clinical Trial Network
14.12.2006 Key Herceptin Data Presented at San Antonio Breast Cancer Symposium
12.12.2006 New Data Demonstrate Clinical Activity of Vidaza(R) in Combination With HDAC Inhibitors in the Treatment of Higher-Risk MDS and AML
12.12.2006 New Data Show That the Addition of Thalidomide to Myeloma Therapies Can Enhance Clinical Activity
11.12.2006 Interim Analysis of Phase III Trial Shows Avastin Plus Interferon Therapy Improved Progression-Free Survival in Patients With Previously Untreated Advanced Renal Cell Carcinoma
10.12.2006 Final Phase 2 Data Continue to Show Promising Results after One Year of Aranesp(R) Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS)
09.12.2006 Data Show Efficacy of Extended Dosing of Aranesp(R) in the Treatment of Chemotherapy-Induced Anemia
09.12.2006 New Phase 2 Data Show Promise of Aranesp(R) Treatment for Anemia of Cancer
08.12.2006 Oxford Biomedica's TROVAX® Receives Postive Recommendation For Orphan Drug Designation In Renal Cancer From EMEA
08.12.2006 Solvay’s SLV 319 obesity candidate treatment advances in phase II clinical trials
